Avanos Medical, INC DEF 14A proxy statements

Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.

NYSE
Avanos Medical, Inc. announces its 2026 Annual Meeting of Stockholders to address director elections, auditor ratification, executive compensation, and an amendment to its long-term incentive plan.
NYSE
Avanos Medical, Inc. is holding its 2025 Annual Meeting of Stockholders on April 24, 2025, and provides information on how to vote on key proposals.
NYSE
Avanos Medical is asking stockholders to approve an amendment to its 2021 Long Term Incentive Plan to increase the number of shares available for issuance by 2,250,000 at the upcoming annual meeting.
NYSE
Avanos Medical, Inc. announces its 2024 Annual Meeting of Stockholders to be held on April 25, 2024, and provides information on accessing proxy materials and voting.
NYSE
Avanos Medical has set the date for its 2024 Annual Meeting of Stockholders on April 25, 2024, and released related proxy materials.